Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine user uptake and experience with a clinical chatbot that automates hereditary cancer risk triage by collecting personal and family cancer history in routine women's health care settings. METHODS: We conducted a multicenter, retrospective observational study of patients who used a web-based chatbot before routine care appointments to assess their risk for hereditary breast and ovarian cancer, Lynch syndrome, and adenomatous polyposis syndromes. Outcome measures included uptake and completion of the risk-assessment and educational section of the chatbot interaction and identification of hereditary cancer risk as evaluated against National Comprehensive Cancer Network criteria. RESULTS: Of the 95,166 patients invited, 61,070 (64.2%) engaged with the clinical chatbot. The vast majority completed the cancer risk assessment (89.4%), and most completed the genetic testing education section (71.4%), indicating high acceptability among those who opted to engage. The mean duration of use was 15.4 minutes (SD 2 hours, 56.2 minutes) when gaps of inactivity longer than 5 minutes were excluded. A personal history of cancer was reported by 19.1% (10,849/56,656) and a family history of cancer was reported by 66.7% (36,469/54,652) of patients who provided the relevant information. One in four patients (14,850/54,547) screened with the chatbot before routine care appointments met National Comprehensive Cancer Network criteria for genetic testing. Among those who were tested, 5.6% (73/1,313) had a disease-causing pathogenic variant. CONCLUSION: A chatbot digital health tool can help identify patients at high risk for hereditary cancer syndromes before routine care appointments. This scalable intervention can effectively provide cancer risk assessment, engage patients with educational information, and facilitate a path toward preventive genetic testing. FUNDING SOURCE: Implementation of the chatbot in clinics was funded by industry support from commercial genetic testing laboratories Ambry, Invitae, and Progenity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
Kuchenbaecker, K. B., Hopper, J. L., Barnes, D. R., Phillips, K.-A., Mooij, T. M., Roos-Blom, M.-J., Jervis, S., van Leeuwen, F. E., Milne, R. L., Andrieu, N., et al. (2017) · JAMA · doi:10.1001/jama.2017.7112 · Cited by 2,954
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Clinical outcomes of a genomic screening program for actionable genetic conditions
Buchanan, A. H., Lester Kirchner, H., Schwartz, M. L. B., Kelly, M. A., Schmidlen, T., Jones, L. K., Hallquist, M. L. G., Rocha, H., Betts, M., Schwiter, R., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0876-4 · Cited by 143
Nelson, H. D., Fu, R., Zakher, B., Pappas, M., & McDonagh, M. (2019) · JAMA · doi:10.1001/jama.2019.5780 · Cited by 137
Trust me, i'm a chatbot: how artificial intelligence in health care fails the Turing Test
Powell, J. (2019) · Journal of Medical Internet Research · doi:10.2196/16222 · Cited by 115
Cited by
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review
Laymouna, M., Ma, Y., Lessard, D., Schuster, T., Engler, K., & Lebouché, B. (2024) · Journal of Medical Internet Research · doi:10.2196/56930 · Cited by 305
Roles, Users, Benefits, and Limitations of Chatbots in Health Care: Rapid Review (Preprint)
Laymouna, M., Ma, Y., Lessard, D., Schuster, T., Engler, K., & Lebouché, B. (2024) · doi:10.2196/preprints.56930 · Cited by 302
Hindelang, M., Sitaru, S., & Zink, A. (2024) · JMIR Medical Informatics · doi:10.2196/56628 · Cited by 79
The Use of Chatbots in Oncological Care: A Narrative Review
Wang, A., Qian, Z., Briggs, L., Cole, A. P., Reis, L. O., & Trinh, Q.-D. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s408208 · Cited by 73
Al-Hilli, Z., Noss, R., Dickard, J., Wei, W., Chichura, A., Wu, V., Renicker, K., Pederson, H. J., & Eng, C. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13888-4 · Cited by 63
Metadata
- Authors
- Nazareth, S., Hayward, L., Simmons, E., Snir, M., Hatchell, K. E., Rojahn, S., Slotnick, R. N., & Nussbaum, R. L.
- Venue
- Obstetrics & Gynecology
- Published
- 2021-11-04
- Volume
- 138
- Issue
- 6
- Pages
- 860-870
- ISSN
- 0029-7844 (ISSN-L)
- OpenAlex
- W3208231941
- Cited by
- 85
- References
- 5
- FWCI
- 6.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits. https://app.cochat.ai/papers/10.1097/aog.0000000000004596
- The paper
- Nazareth, S., Hayward, L., Simmons, E., Snir, M., Hatchell, K. E., Rojahn, S., Slotnick, R. N., & Nussbaum, R. L. (2021). Hereditary Cancer Risk Using a Genetic Chatbot Before Routine Care Visits. Obstetrics & Gynecology. https://doi.org/10.1097/aog.0000000000004596
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.